Brado AI joins Coalition for Health AI (CHAI) to advance health AI governance, signaling a strategic push toward clinically governed, provider‑anchored artificial intelligence in U.S. health systems. Brado AI’s move comes at a time when the healthcare sector is wrestling with the twin challenges of scaling AI‑driven patient engagement while ensuring compliance, safety, and trust. The St. Louis‑based health‑tech firm announced on July 22... Read More

DarioHealth’s new DarioIQ AI platform promises to lift Business‑to‑Business‑to‑Consumer (B2B2C) recurring revenue by up to 15 % by delivering hyper‑personalized health‑management experiences, a move that could reshape how insurers, employers and health systems engage chronic‑condition members. What DarioIQ Offers DarioIQ combines more than 13 billion de‑identified health data points with generative AI and agentic AI to decide... Read More

Insilico Medicine has moved its AI‑designed TNIK inhibitor, Rentosertib, into a Phase III clinical trial, marking a rare end‑to‑end showcase of generative‑AI drug discovery for idiopathic pulmonary fibrosis (IPF). Insilico Medicine, the Hong Kong‑listed biotech that builds its pipeline on generative‑AI platforms such as Pharma.AI, announced on July 7 that the once‑daily oral molecule Rentosertib will enter... Read More

Oracle Health and Theator launch AI surgical reporting Oracle Health and Theator announced a joint effort to embed AI-driven operative documentation into Oracle’s enterprise health platform. Leveraging Theator’s video‑capture and analysis technology on Oracle Cloud Infrastructure (OCI), the partnership aims to replace manual dictation with automatically generated, clinically accurate operative notes that feed directly into... Read More

San Francisco‑based Assort Health announced a fresh $120 million Series C financing led by Menlo Ventures, pushing the company’s post‑money valuation to $1.2 billion. The round brings the startup’s total capital raised to more than $222 million, underscoring investor confidence in its end‑to‑end AI platform for healthcare access. A market burden ripe for automation Administrative overhead still consumes roughly twice... Read More

Advita Ortho, the multinational medical‑device firm, used the 26th Annual Meeting of the International Society for Computer Assisted Orthopaedic Surgery (CAOS) to unveil a suite of nine peer‑reviewed studies that explore how artificial intelligence, automated planning and real‑time navigation can reshape joint replacement procedures. The research spans shoulder, knee and ankle interventions, offering a granular... Read More